News

Kuros Biosciences grows sales to CHF 75.6 million for 2024

Schlieren (Zurich), Switzerland, March 11, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial and operational results for the full year 2024, marking another year of record growth, increased market penetration, and strategic portfolio advancements. Revenue from Direct MagnetOs...

read more

hemotune AG Expands ISO 13485 Certification

Schlieren-based medical device company Hemotune AG has received dual certification for its blood purification process. According to a press release, the company has received ISO 13485:2016 certification for both sterile and non-sterile medical devices and nanoparticles for blood purification. ISO 13485 is the internationally recognized standard for quality management systems in...

read more